• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 39-53 of 134 results

1039 Exhibit: Arthur A Hancock, Analysis of the Hypotensive Effects of Medroxalol ...

Document IPR2016-00379, No. 1039-2 Exhibit - Arthur A Hancock, Analysis of the Hypotensive Effects of Medroxalol and Its Enantioners, Clin and Exper Hyper Theory and Practice, A63, at 659 684 (P.T.A...

cite Cite Document

1002 Exhibit: Excerpts of Prosecution History for the 040 Patent

Document IPR2016-00379, No. 1002-2 Exhibit - Excerpts of Prosecution History for the 040 Patent (P.T.A.B. Jan. 20, 2016)

cite Cite Document

1043 Exhibit: Raymond Xhonneux, et al, The l enantiomer of nebivolol potentiates t...

Document IPR2016-00379, No. 1043-2 Exhibit - Raymond Xhonneux, et al, The l enantiomer of nebivolol potentiates the blood pressure lowering effect of the denantiomer, 181 European Journal of Pharma...

cite Cite Document

1012 Exhibit: Stig G Allenmark, CHROMATOGRAPHIC ENANTIOSEPARATION, Ch...

Document IPR2016-00379, No. 1012-2 Exhibit - Stig G Allenmark, CHROMATOGRAPHIC ENANTIOSEPARATION, Ch 4 at 42 63 (P.T.A.B. Jan. 20, 2016)

cite Cite Document

1044 Exhibit: G Van Lomen, et al, Synthesis and Pharmacological Properties of Ne...

Document IPR2016-00379, No. 1044-2 Exhibit - G Van Lomen, et al, Synthesis and Pharmacological Properties of Nebivolol, a new antihypertensive compound, 45 Journal de pharmacie de Belgique at 355...

cite Cite Document

1028 Exhibit: Edward Freis, MD, Validity of Therapy For Mild Hypertension, 30 Ann ...

Document IPR2016-00379, No. 1028-2 Exhibit - Edward Freis, MD, Validity of Therapy For Mild Hypertension, 30 Ann Rev Med at 81 89 (P.T.A.B. Jan. 20, 2016)

cite Cite Document

1030 Exhibit: William B Stason, Opportunities for Improving the Cost Effectiveness ...

Document IPR2016-00379, No. 1030-2 Exhibit - William B Stason, Opportunities for Improving the Cost Effectiveness of Antihypertensive Treatment, 81 The American Journal of Medicine at 45 49 (P.T.A.B...

cite Cite Document

1024 Exhibit: H Y Aboul Enein and I Ali, HPLC enantiomeric resolution of nebivolol o...

Document IPR2016-00379, No. 1024-2 Exhibit - H Y Aboul Enein and I Ali, HPLC enantiomeric resolution of nebivolol on normal and reversed amylose based chiral phases, 56 Pharmazie, at 214 216 (P.T.A...

cite Cite Document

1052 Exhibit: Declaration under 37 CFR 4253a by Ronald W Millard, PhD

Document IPR2016-00379, No. 1052-2 Exhibit - Declaration under 37 CFR 4253a by Ronald W Millard, PhD (P.T.A.B. Jan. 20, 2016)

cite Cite Document

1010 Exhibit: Veronika R Meyer, PRACTICAL HIGH PERFORMANCE LIQUID CHRO...

Document IPR2016-00379, No. 1010-2 Exhibit - Veronika R Meyer, PRACTICAL HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (P.T.A.B. Jan. 20, 2016)

cite Cite Document

1021 Exhibit: CYCLOBOND HANDBOOK, Advanced Separation Technologies Inc

Document IPR2016-00379, No. 1021-2 Exhibit - CYCLOBOND HANDBOOK, Advanced Separation Technologies Inc (P.T.A.B. Jan. 20, 2016)

cite Cite Document

1049 Exhibit: Actavis UK Limited and Janssen Pharmaceutica NV, Case No HC070...

Document IPR2016-00379, No. 1049-2 Exhibit - Actavis UK Limited and Janssen Pharmaceutica NV, Case No HC0700 572,In the High Court of Justice, Chancery Division, Patent Court, 2008 EWHC 1422 (P...

cite Cite Document

1032 Exhibit: David B Bylund, Adrenergic Receptors, The Adrenergic Receptors in ...

Document IPR2016-00379, No. 1032-2 Exhibit - David B Bylund, Adrenergic Receptors, The Adrenergic Receptors in the 21st Century, Chapter 1 (P.T.A.B. Jan. 20, 2016)

cite Cite Document

1023 Exhibit: CHIRAL SEPARATIONS, D Stevenson and I D Wilson, eds, 1988

Document IPR2016-00379, No. 1023-2 Exhibit - CHIRAL SEPARATIONS, D Stevenson and I D Wilson, eds, 1988 (P.T.A.B. Jan. 20, 2016)

cite Cite Document

1013 Exhibit: Stig G Allenmark, CHROMATOGRAPHIC ENANTIOSEPARATION, Ch...

Document IPR2016-00379, No. 1013-2 Exhibit - Stig G Allenmark, CHROMATOGRAPHIC ENANTIOSEPARATION, Ch 5 at 64 74 (P.T.A.B. Jan. 20, 2016)

cite Cite Document
<< 1 2 3 4 5 6 7 8 9 10 >>